Company Valuation: Clarity Medical Group Holding Limited

Data adjusted to current consolidation scope
Fiscal Period: March 2022 2023 2024
Market Cap 1 637.1 496.4 359.1
Change - -22.08% -27.66%
Enterprise Value (EV) 1 416.1 336.2 243.1
Change - -19.19% -27.69%
P/E 36.2x -154x -4.71x
PBR 2.49x 1.91x 1.89x
PEG -0.6x 1x -0x
Capitalization / Revenue 2.83x 2.32x 1.88x
EV / Revenue 1.85x 1.57x 1.27x
EV / EBITDA 9.63x -218x -6.03x
EV / EBIT 11.7x -43.5x -4.32x
EV / FCF - - -
FCF Yield - - -
Dividend per Share 2 - - -
Rate of return - - -
EPS 2 0.0346 -0.006108 -0.1444
Distribution rate - - -
Net sales 1 225.2 213.8 190.9
EBITDA 1 43.19 -1.543 -40.34
EBIT 1 35.49 -7.722 -56.23
Net income 1 13.49 -3.191 -75.79
Net Debt 1 -221.1 -160.2 -116
Reference price 2 1.2500 0.9400 0.6800
Nbr of stocks (in thousands) 509,718 528,125 528,125
Announcement Date 7/27/22 7/28/23 7/26/24
1HKD in Million2HKD
Estimates

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 24.27M
31.44x3x13.42x1.38% 17.74B
51.08x4.39x28.59x0.27% 13.23B
19.16x2.28x10.62x0.65% 12.05B
21.99x3.09x11.01x1.96% 11.78B
25.85x2.08x16.78x0.15% 10.55B
87.33x7.58x29.36x - 9.95B
19.06x2.72x11x4.19% 9.31B
12.73x1.29x8.25x2.16% 7.53B
34.08x0.94x7.81x1.9% 7.28B
Average 33.63x 3.04x 15.21x 1.58% 9.94B
Weighted average by Cap. 34.06x 3.16x 15.74x 1.45%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. 1406 Stock
  4. Valuation Clarity Medical Group Holding Limited